Literature DB >> 33383373

Alpiniae oxyphyllae Fructus and Alzheimer's disease: An update and current perspective on this traditional Chinese medicine.

Jia Li1, Qiuzheng Du1, Na Li2, Shuzhang Du3, Zhi Sun4.   

Abstract

Alzheimer's disease (AD) is a common progressive neuro-degenerative disease, and the morbidity and mortality are still on the rise. In spite of recent advances in AD treatment, their clinical efficacy has been limited, non-curative and easy to drug resistance. Alpiniae oxyphyllae Fructus (AOF), derived from the dried and mature fruits of the Zingiberaceae plant Alpinia oxyphylla Miq, is a choice in traditional Chinese medicine to treat AD, which has a good effect and has been used for a long time. Recent studies have demonstrated its potent activities in modulating multiple signaling pathways associated with β-amyloid deposition, tau protein phosphorylation, chronic inflammation, oxidative stress. The neuropharmacological mechanism of AOF in AD have been fully illustrated in numerous studies. In this review, we first briefly described the active components of AOF and related mechanism for treating AD. And we also provide a systematic overview of recent progress on the pharmacokinetic characteristics of the active ingredients of AOF and analyzed their bioavailability differences in the development of AD. Thus, AOF hold a great therapeutic potential in the treatment of AD and is worthy of further research and promotion.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Alpiniae oxyphyllae Fructus; Alzheimer’s disease; Chrysin; Nootkatone; Parmacokinetics; Protocatechuic acid

Mesh:

Substances:

Year:  2020        PMID: 33383373     DOI: 10.1016/j.biopha.2020.111167

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Thioredoxin-1 inhibits amyloid-β25-35-induced activation of NLRP1/caspase-1/GSDMD pyroptotic pathway in PC12 cells.

Authors:  Jinjing Jia; Xinhong Zhang; Guangtao Xu; Xiansi Zeng; Li Li
Journal:  Mol Biol Rep       Date:  2022-01-24       Impact factor: 2.316

2.  Nootkatone, a Sesquiterpene Ketone From Alpiniae oxyphyllae Fructus, Ameliorates Metabolic-Associated Fatty Liver by Regulating AMPK and MAPK Signaling.

Authors:  Zhang Yong; Huang Zibao; Zhou Zhi; Ma Ning; Wang Ruiqi; Chen Mimi; He Xiaowen; Dong Lin; Xia Zhixuan; Liu Qiang; Lu Weiying; Zhang Xiaopo
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

3.  Complete Chloroplast Genome Analysis of Two Important Medicinal Alpinia Species: Alpinia galanga and Alpinia kwangsiensis.

Authors:  Yue Zhang; Mei-Fang Song; Yao Li; Hui-Fang Sun; Dei-Ying Tang; An-Shun Xu; Cui-Yun Yin; Zhong-Lian Zhang; Li-Xia Zhang
Journal:  Front Plant Sci       Date:  2021-12-15       Impact factor: 5.753

Review 4.  Medicine-Food Herbs against Alzheimer's Disease: A Review of Their Traditional Functional Features, Substance Basis, Clinical Practices and Mechanisms of Action.

Authors:  Pengfei Guo; Baoyue Zhang; Jun Zhao; Chao Wang; Zhe Wang; Ailin Liu; Guanhua Du
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

5.  Protective Effects of Nootkatone on Renal Inflammation, Apoptosis, and Fibrosis in a Unilateral Ureteral Obstructive Mouse Model.

Authors:  Chang-Mu Chen; Chen-Yu Lin; Yao-Pang Chung; Chia-Hung Liu; Kuo-Tong Huang; Siao-Syun Guan; Cheng-Tien Wu; Shing-Hwa Liu
Journal:  Nutrients       Date:  2021-11-01       Impact factor: 5.717

6.  Alpiniae oxyphyllae fructus possesses neuroprotective effects on H2O2 stimulated PC12 cells via regulation of the PI3K/Akt signaling Pathway.

Authors:  Ruolan Li; Lingyu Wang; Qing Zhang; Huxinyue Duan; Die Qian; Fei Yang; Jun Xia
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

Review 7.  Medicinal Herbs and Their Derived Ingredients Protect against Cognitive Decline in In Vivo Models of Alzheimer's Disease.

Authors:  Yueh-Ting Tsai; Shung-Te Kao; Chin-Yi Cheng
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.